心臟帮浦设备市场规模、份额及成长分析（按产品、类型、疗法和地区）- 产业预测 2025-2032

2023 年心臟帮浦设备市场规模价值为 31 亿美元，预计将从 2024 年的 37.8 亿美元成长到 2032 年的 185.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 22.0%。

由于心血管疾病发病率不断上升以及心臟衰竭发病率不断上升，全球心臟泵设备市场正在经历强劲增长。我们全面的价值链分析可协助製造商透过创新获得竞争优势。人口老化进一步推动了对这些关键设备的需求，这些设备对于支持患有严重心臟疾病的患者至关重要。小型化和增强功能等技术进步显着提高了患者的治疗效果和采用率。特别是磁浮辅助人工心臟（VAD）的出现改变了整个医疗体系，它能够提供卓越的心臟支持并且併发症更少。此外，对于合格移植的病人，转向机械循环支援作为永久的解决方案正在扩大市场机会，特别是在美国，预计该市场将以持续的复合年增长率成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究分析

心臟泵设备市场规模（按产品和复合年增长率） (2025-2032)

• 市场概况
• 辅助人工心臟
  • 左心室辅助装置
  • 经皮心室辅助装置
  • 双心室辅助装置
  • 右心室辅助装置
• 主动脉内球囊泵
• 人工心臟总数

心臟泵设备市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• 植入式心臟帮浦装置
• 体外心臟帮浦装置

心臟帮浦设备市场规模（依疗法和复合年增长率） (2025-2032)

• 市场概况
• 植入式辅助人工心臟(BTT)
• 移植登记桥樑（BTC）
• 目的地治疗（DT）
• 其他治疗方法

心臟泵设备市场规模（按地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（US）
• Medtronic PLC（Ireland）
• LivaNova PLC（United Kingdom）
• Berlin Heart GmbH（Germany）
• Getinge AB（Sweden）
• Terumo Corporation（Japan）
• Teleflex Incorporated（US）
• Jarvik Heart, Inc.（US）
• Fresenius Medical Care AG & Co. KGaA（Germany）
• Calon Cardio（United Kingdom）
• BiVACOR Inc.（Australia）
• Leviticus Cardio Ltd.（Israel）
• CARMAT SA（France）
• FineHeart SA（France）
• MyLVAD（US）
• MicroPort Scientific Corporation（China）
• TandemLife, a LivaNova company（US）

结论和建议

Heart Pump Device Market size was valued at USD 3.1 billion in 2023 and is poised to grow from USD 3.78 billion in 2024 to USD 18.56 billion by 2032, growing at a CAGR of 22.0% during the forecast period (2025-2032).

The global heart pump device market is witnessing robust growth, driven by the rising prevalence of cardiovascular diseases and the increasing incidence of heart failure. As manufacturers leverage our comprehensive value chain analysis, they can enhance their competitive advantage through innovation. The aging population is further fueling demand for these critical devices, essential for supporting patients with severe cardiac conditions. Technological advancements, such as miniaturization and improved functionality, have significantly boosted patient outcomes and adoption rates. Notably, the emergence of magnetically levitated ventricular assist devices (VADs) has transformed the landscape, offering superior heart support with fewer complications. Additionally, the shift towards mechanical circulatory support as a permanent solution for patients ineligible for transplant is expanding market opportunities, particularly in the U.S., where sustainable CAGR growth is anticipated.

Top-down and bottom-up approaches were used to estimate and validate the size of the Heart Pump Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Heart Pump Device Market Segments Analysis

Global Heart Pump Device Market is segmented by Product, Type, Therapy and region. Based on Product, the market is segmented into Ventricular Assist Devices, Intra-Aortic Balloon Pumps and Total Artificial Hearts. Based on Type, the market is segmented into Implantable Heart Pump Devices and Extracorporeal Heart Pump Devices. Based on Therapy, the market is segmented into Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT) and Other Therapies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Heart Pump Device Market

Continuous innovation in heart pump technology has tremendously enhanced the performance and efficacy of these devices, driving the Heart Pump Device market. Recent advancements have produced smaller, more resilient, and efficient heart pumps, significantly boosting patient comfort and overall quality of life. A notable example is the emergence of magnetically levitated ventricular assist devices (LVADs), which have minimized device-related complications while yielding better patient outcomes. This ongoing development not only addresses the immediate needs of patients with heart failure but also underscores the commitment of manufacturers to improve heart pump solutions, ultimately expanding market potential and fostering growth in the healthcare industry.

Restraints in the Heart Pump Device Market

The heart pump device market faces notable constraints primarily due to the intricate and advanced nature of these medical technologies, which results in high manufacturing and acquisition costs. This substantial financial burden impacts patients, healthcare providers, and healthcare systems, limiting access to these essential devices. Additionally, inadequate reimbursement coverage for heart pump devices in certain areas further complicates the situation, making it challenging for patients to obtain these critical technologies. As a result, the combination of prohibitive costs and limited financial support inhibits the widespread adoption and utilization of heart pump devices, ultimately affecting patient care and outcomes.

Market Trends of the Heart Pump Device Market

The Heart Pump Device market is witnessing a notable trend towards the integration of compatible devices that enhance pump performance and patient outcomes. This includes advanced control units that optimize pump flow management and tailored power sources providing extended battery life, ensuring uninterrupted operation. Furthermore, the incorporation of sophisticated monitoring and data management features facilitates real-time remote patient tracking, significantly improving care coordination. As healthcare providers increasingly prioritize personalized, efficient solutions, the surge in demand for these compatible technologies is transforming the landscape of cardiovascular care, driving innovation and growth within the heart pump device sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Study Analysis

Global Heart Pump Device Market Size by Product & CAGR (2025-2032)

• Market Overview
• Ventricular Assist Devices
  • Left Ventricular Assist Devices
  • Percutaneous Ventricular Assist Devices
  • Biventricular Assist Devices
  • Right Ventricular Assist Devices
• Intra-Aortic Balloon Pumps
• Total Artificial Hearts

Global Heart Pump Device Market Size by Type & CAGR (2025-2032)

• Market Overview
• Implantable Heart Pump Devices
• Extracorporeal Heart Pump Devices

Global Heart Pump Device Market Size by Therapy & CAGR (2025-2032)

• Market Overview
• Bridge-To-Transplant (BTT)
• Bridge-To-Candidacy (BTC)
• Destination Therapy (DT)
• Other Therapies

Global Heart Pump Device Market Size & CAGR (2025-2032)

• North America (Product, Type, Therapy)
  • US
  • Canada
• Europe (Product, Type, Therapy)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Therapy)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Therapy)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Therapy)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic PLC (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Calon Cardio (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVACOR Inc. (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Leviticus Cardio Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CARMAT SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FineHeart SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyLVAD (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TandemLife, a LivaNova company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations